Thomas T Tsai1, Uptal D Patel2, Tara I Chang3, Kevin F Kennedy4, Frederick A Masoudi5, Michael E Matheny6, Mikhail Kosiborod4, Amit P Amin4, John C Messenger5, John S Rumsfeld7, John A Spertus4. 1. Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado; University of Colorado Denver, Denver, Colorado. Electronic address: thomas.tsai@coloradooutcomes.org. 2. Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina. 3. Stanford School of Medicine, Palo Alto, California. 4. Mid America Heart Institute, Kansas City, Missouri; University of Missouri at Kansas City School of Medicine, Kansas City, Missouri. 5. Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado. 6. Tennessee Valley Health System VA, Nashville, Tennessee; Vanderbilt University Medical Center, Nashville, Tennessee. 7. Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado; Denver VA Medical Center, Denver, Colorado.
Abstract
OBJECTIVES: This study sought to examine the contemporary incidence, predictors and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions. BACKGROUND: Acute kidney injury (AKI) is a serious and potentially preventable complication of percutaneous coronary interventions (PCIs) that is associated with adverse outcomes. The contemporary incidence, predictors, and outcomes of AKI are not well defined, and clarifying these can help identify high-risk patients for proactive prevention. METHODS: A total of 985,737 consecutive patients underwent PCIs at 1,253 sites participating in the National Cardiovascular Data Registry Cath-PCI registry from June 2009 through June 2011. AKI was defined on the basis of changes in serum creatinine level in the hospital according to the Acute Kidney Injury Network (AKIN) criteria. Using multivariable regression analyses with generalized estimating equations, we identified patient characteristics associated with AKI. RESULTS: Overall, 69,658 (7.1%) patients experienced AKI, with 3,005 (0.3%) requiring new dialysis. On multivariable analyses, the factors most strongly associated with development of AKI included ST-segment elevation myocardial infarction (STEMI) presentation (odds ratio [OR]: 2.60; 95% confidence interval [CI]: 2.53 to 2.67), severe chronic kidney disease (OR: 3.59; 95% CI: 3.47 to 3.71), and cardiogenic shock (OR: 2.92; 95% CI: 2.80 to 3.04). The in-hospital mortality rate was 9.7% for patients with AKI and 34% for those requiring dialysis compared with 0.5% for patients without AKI (p < 0.001). After multivariable adjustment, AKI (OR: 7.8; 95% CI: 7.4 to 8.1, p < 0.001) and dialysis (OR: 21.7; 95% CI: 19.6 to 24.1; p < 0.001) remained independent predictors of in-hospital mortality. CONCLUSIONS: Approximately 7% of patients undergoing a PCI experience AKI, which is strongly associated with in-hospital mortality. Defining strategies to minimize the risk of AKI in patients undergoing PCI are needed to improve the safety and outcomes of the procedure.
OBJECTIVES: This study sought to examine the contemporary incidence, predictors and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions. BACKGROUND:Acute kidney injury (AKI) is a serious and potentially preventable complication of percutaneous coronary interventions (PCIs) that is associated with adverse outcomes. The contemporary incidence, predictors, and outcomes of AKI are not well defined, and clarifying these can help identify high-risk patients for proactive prevention. METHODS: A total of 985,737 consecutive patients underwent PCIs at 1,253 sites participating in the National Cardiovascular Data Registry Cath-PCI registry from June 2009 through June 2011. AKI was defined on the basis of changes in serum creatinine level in the hospital according to the Acute Kidney Injury Network (AKIN) criteria. Using multivariable regression analyses with generalized estimating equations, we identified patient characteristics associated with AKI. RESULTS: Overall, 69,658 (7.1%) patients experienced AKI, with 3,005 (0.3%) requiring new dialysis. On multivariable analyses, the factors most strongly associated with development of AKI included ST-segment elevation myocardial infarction (STEMI) presentation (odds ratio [OR]: 2.60; 95% confidence interval [CI]: 2.53 to 2.67), severe chronic kidney disease (OR: 3.59; 95% CI: 3.47 to 3.71), and cardiogenic shock (OR: 2.92; 95% CI: 2.80 to 3.04). The in-hospital mortality rate was 9.7% for patients with AKI and 34% for those requiring dialysis compared with 0.5% for patients without AKI (p < 0.001). After multivariable adjustment, AKI (OR: 7.8; 95% CI: 7.4 to 8.1, p < 0.001) and dialysis (OR: 21.7; 95% CI: 19.6 to 24.1; p < 0.001) remained independent predictors of in-hospital mortality. CONCLUSIONS: Approximately 7% of patients undergoing a PCI experience AKI, which is strongly associated with in-hospital mortality. Defining strategies to minimize the risk of AKI in patients undergoing PCI are needed to improve the safety and outcomes of the procedure.
Authors: Spencer B King; Sidney C Smith; John W Hirshfeld; Alice K Jacobs; Douglass A Morrison; David O Williams; Ted E Feldman; Morton J Kern; William W O'Neill; Hartzell V Schaff; Patrick L Whitlow; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy Journal: J Am Coll Cardiol Date: 2008-01-15 Impact factor: 24.094
Authors: Mauro Maioli; Anna Toso; Michela Gallopin; Mario Leoncini; Delio Tedeschi; Carlo Micheletti; Francesco Bellandi Journal: J Cardiovasc Med (Hagerstown) Date: 2010-06 Impact factor: 2.160
Authors: Troy E Madsen; Robert R Pearson; Joseph B Muhlestein; Donald L Lappé; Tami L Bair; Benjamin D Horne; Jeffrey L Anderson Journal: Crit Pathw Cardiol Date: 2009-12
Authors: Jeremiah R Brown; James T DeVries; Winthrop D Piper; John F Robb; Michael J Hearne; Peter M Ver Lee; Mirle A Kellet; Mathew W Watkins; Thomas J Ryan; M Theodore Silver; Cathy S Ross; Todd A MacKenzie; Gerald T O'Connor; David J Malenka Journal: Am Heart J Date: 2007-11-26 Impact factor: 4.749
Authors: Britt B Newsome; David G Warnock; William M McClellan; Charles A Herzog; Catarina I Kiefe; Paul W Eggers; Jeroan J Allison Journal: Arch Intern Med Date: 2008-03-24
Authors: Sameer K Mehta; Andrew D Frutkin; Jason B Lindsey; John A House; John A Spertus; Sunil V Rao; Fang-Shu Ou; Matthew T Roe; Eric D Peterson; Steven P Marso Journal: Circ Cardiovasc Interv Date: 2009-05-08 Impact factor: 6.546
Authors: Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: David M Safley; Adam C Salisbury; Thomas T Tsai; Eric A Secemsky; Kevin F Kennedy; R Kevin Rogers; Faisal Latif; Nicolas W Shammas; Lawrence Garcia; Matthew A Cavender; Kenneth Rosenfield; Anand Prasad; John A Spertus Journal: JACC Cardiovasc Interv Date: 2021-02-08 Impact factor: 11.195
Authors: Michael Robert Marchick; Brandon Russell Allen; Emily Cassin Weeks; Jonathan Jacob Shuster; Marie-Carmelle Elie Journal: Intern Emerg Med Date: 2016-02-24 Impact factor: 3.397
Authors: John A Dodson; Alexandra Hajduk; Jeptha Curtis; Mary Geda; Harlan M Krumholz; Xuemei Song; Sui Tsang; Caroline Blaum; Paula Miller; Chirag R Parikh; Sarwat I Chaudhry Journal: Am J Med Date: 2019-06-04 Impact factor: 4.965
Authors: Krishna K Patel; Suzanne V Arnold; Philip G Jones; Mohammed Qintar; Karen P Alexander; John A Spertus Journal: Am J Cardiol Date: 2018-01-10 Impact factor: 2.778